Microchip Biotechnologies Inc Company Profile

Microchip Biotechnologies, Inc. (MBI) headquartered in Pleasanton, CA, is a venture-backed, privately held company that has developed and is producing superior sample processing systems for life sciences, applied sciences, and diagnostics markets. The company's products are based on the Apollo next-generation fluidics technology platform that integrates advanced fluidics and analytical capabilities to produce sample-to-answer performance for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, as well as molecular diagnostics applications. The company's first product, the Apollo 100 System, enables customers to significantly reduce an expensive and time-consuming sample preparation bottleneck within Sanger cycle sequencing with a fully automated laboratory workflow and bead-based cleanup procedure. The efficiency of the Apollo 100 process dramatically reduces the use of expensive sequencing reagents.